Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
about
Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survivalAlpha 1 adrenoreceptor antagonistsPotential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertensionALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesMortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanismsSympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsBlood pressure control in type 2 diabetic patients.Current perspectives on systemic hypertension in heart failure with preserved ejection fraction.Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.Synthesis of beta-enantiomers of N4-hydroxy-3'-deoxypyrimidine nucleosides and their evaluation against bovine viral diarrhoea virus and hepatitis C virus in cell culture.A Practical Approach to Hypertension Management in DiabetesThiazides in the management of hypertension in older adults - a systematic review.
P2860
Q26827620-AA59AB8A-CF7B-41CA-9141-AE8F95428016Q27023133-F3413387-073C-471C-B629-7B1B8DBD184FQ28575913-25143F0C-DAB8-41E9-88AA-40C900D59F87Q33576830-11D3DFA6-EBF4-4BA9-98E8-8818D6B48460Q33965660-1BCD8D9A-DB68-4883-823F-CCE4B61C6D9EQ36093354-2985B038-1FB0-430E-A33D-49CD7494F1EFQ37518344-96A61979-A12C-4B93-9D90-41932CFBC59FQ37566950-F5F55E9C-0439-4B50-990C-361CFF60A59DQ38261197-23D0B2A3-758E-4E01-8934-C95786A1907FQ39096331-CFE3BFE3-520E-4E04-B5BF-12699FA297A7Q40568435-891A33CD-B7D3-4B21-8FD0-096E47669326Q42371757-06E6A776-3AC2-4783-A232-9F012B5BA9D2Q42676664-7E8A6C08-45FC-480D-A05B-D713206FD902
P2860
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Cardiovascular outcomes using ...... report from the ALLHAT study.
@en
Cardiovascular outcomes using ...... report from the ALLHAT study.
@nl
type
label
Cardiovascular outcomes using ...... report from the ALLHAT study.
@en
Cardiovascular outcomes using ...... report from the ALLHAT study.
@nl
prefLabel
Cardiovascular outcomes using ...... report from the ALLHAT study.
@en
Cardiovascular outcomes using ...... report from the ALLHAT study.
@nl
P2093
P2860
P1476
Cardiovascular outcomes using ...... report from the ALLHAT study.
@en
P2093
ALLHAT Collaborative Research Group
Allan Ellsworth
Barry R Davis
David C Goff
Gabriel Habib
Henry Black
Jan N Basile
Jerry O Ciocon
Joshua I Barzilay
Judy Bettencourt
P2860
P304
P356
10.1111/J.1524-6175.2004.03216.X
P577
2004-03-01T00:00:00Z